SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cheech who wrote (95)2/23/1997 4:38:00 PM
From: Claud B   of 7041
 
I left my crystal ball at work, so I don't know what the movement
in the stock will be this week. As I've said before, it doesn't matter
short term.

IMO, Vasomax (with FDA approval, of course) will probably hit the
market first.

"This news" as you put it, is not "news." It's a story written
by an editorial writer for Barrons. It will have ZERO effect
on any announcement Zonagen will or will not make.

They will release the results of Phase III when they become
available. Not sooner or later. This article merely points out
what is going on in the financial community with regard
to the field of male impotency. It could have just as easily
been an article on what's new in the field of photography,
semi conductors, or whatever.

Claud
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext